Clinical Benefit Study Of Senile COPD Patients In Stationary Phase Combined With Frailty With The Lung And Spleen Qi Deficiency Syndrome Treated With Liujunzi Decoction Combined Comprehensive Therapy

Objective: The effects of different treatment methods on COPD stationary phase(lung and spleen qi deficiency syndrome),which was combined with Frailty patients was observed.Observational indicators include clinical symptoms,lung function,quality of life,exercise endurance,etc.Methods: The clinical studies were included in 81 subjects of COPD stationary phase(lung and spleen qi deficiency syndrome)which was combined with Frailty.Them were randomly grouping into 3 groups with 27 patients-the control group,the test1 group,and the test 2 group.The treatment plan of control group was routine western medicine,the test 1 group used Liujunzi Decoction on western medicine plan,and the test 2 group adopt the treatment Liujunzi Decoction combined interventional therapy of Frailty.The observation period of this test was 8 weeks.Observational indicators include clinical symptoms,lung function,quality of life,exercise endurance,TCM score,BMI,6WMT,m MRC,CAT score,and Frail scale before and after treatment of 3 groups(81 subjects).Results: 1.There was scarcely any significant difference in BMI,baseline,pulmonary function,6WMT,m MRC,CAT score,TCM score,and Frail scale before treatment(P>0.05)after comparable.By compared with the control group,there were significant statistically difference improving showed on TCM score,6WMT,m MRC,CAT score,and Frail scale(P<0.05).Meanwhile the improvement of TCM score,CAT score,and6 WMT in the test 2 group was great significantly better than that in the test1group(P<0.05).2.There was barely no significant difference in pulmonary function among three group after treatment(P>0.05).Conclusion: It can be seen that using the Liujunzi Decoction combined interventional therapy of Frailty.in treating patients with COPD is effective.It can improve the dyspnea,exercise endurance,Frail scale,and quality of life of patients with COPD in stationary phase.There was not significant benefits to be observed patients in lung function were.